To save images, click on the links below, then right click on the large image and "Save Picture as" onto your PC.

Board of Directors

Brian Jamieson

   

Donal O’Dwyer, BE, MBA

   

Professor Silviu Itescu, MBBS (Hons), FRACP, FACP, FACR

   

Michael Spooner, BCom, ACA, MAICD

   

Byron McAllister. B.Sc, M.Ag

   



Illustrations

Illustrations



Images

Production of Mesoblast's specialist adult stem cells - Image 1

   

Production of Mesoblast's specialist adult stem cells - Image 2

   

Production of Mesoblast's specialist adult stem cells - Image 3

   

Production of Mesoblast's specialist adult stem cells - Image 4

   

Mesenchymal Precursor Cells

   

Bone Marrow Aspirate

 

 

News Room


 

Last Share Price

August 26 2010- Preliminary 2010 Annual Report

August 26 2010 - Mesoblast Financial Year End Results; Strong Clinical Progress, Major Regulatory Milestone and Enhanced Corporate Strategy

23 August 2010 - EGM documents - Letter from the Chairman, Notice of Meeting, Independent Expert Report.

16 August - Mesoblast on track for phase 3 bone marrow transplant trial following positive meeting with FDA

21 July - Mesoblast receives TGA regulatory approval to commercially manufacture adult stem cell products

12 July - Phase 3 meeting scheduled with FDA following positive results of bone marrow regeneration trial

28 May - Mesoblast featured at ASX Singapore conference highlighting emerging market leaders

19 May - United States FDA Clears Phase 2 Trial for Cervical Spinal Fusion

16 August 2010 - Southern Cross Equities research - Phase III getting ready for takeoff

23 July 2010 - Southern Cross Equities Research – Big Pharma will be watching

21 July 2010 - Southern Cross Equities Research – The clinical endgame nears

17 May 2010 - Southern Cross Equities Research – Capitalising the Stem Cell Opportunity

14 May 2010 - Bioshares

26 February - RBS Equities Research - Mesoblast (Buy) 1H10 - Master Blasters

July 2009 - Chairman’s Letter

May 2009 - Chairman’s Letter

May 2008 - Issue Nine